jCyte Announces Appointment of John Pollack, MD, FASRS, as Chief Medical Officer
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the continued expansion of the company’s executive management team with the appointment of John Pollack, MD, FASRS, as the company’s first Chief Medical Officer (CMO). Dr. Pollack is a retinal clinician, surgeon, and educator, and brings over two decades of clinical, research, and drug development experience in ophthalmol